Companies / Imunon, Inc.

Imunon, Inc.

Nasdaq: IMNNCIK 749647LAWRENCEVILLE, NJ

Financials · FY2022

Revenue$500.0K
Net income$-14.50M
Total debt$6.08M
Cash$6.86M
Diluted EPS$-6.83
Shares outstanding5.6M

Ownership

5.6M shares outstanding · as of Aug 10, 2026
1.5%Insiders
Ownership
Insiders1.48%83,091
10%+ / strategic6.24%349,917
Institutions3.16%177,044
Public float89.13%5,001,351

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 11

View all →
Insider% of sharesShares
Tardugno Michael HExecutive Chairman of Board · Director
1.07%59,986
Dentzer James EDirector
0.27%14,963
Pellizzari Christine ADirector
0.15%8,142
Anwer KhursheedChief Scientific Officer
——
Bragg KimberlyCFO
——
Braun Donald PDirector
——
Church Jeffrey WayneCFO
——
Eylward SusanGeneral Counsel and Corp Sec
——
Faller Douglas VincentChief Medical Officer
——
Fritz Frederick J.Director
——

Institutional holders 20

View all →
HolderValue% of shares
Armistice Capital, LLC$1.02M4.76%
Riverview Capital Advisers, LLC$247.8K0.61%
DRW Securities, LLC$224.1K1.05%
Vanguard Group Inc$141.2K0.66%
Geode Capital Management, LLC$97.6K0.59%
Wells Fargo & COMPANY/MN$13.1K0.06%
Morgan Stanley$11.3K0.05%
BlackRock, Inc.$7.9K0.08%
UBS Group AG$6.1K0.03%
SBI Securities Co., Ltd.$3.9K0.02%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 25, 2026Tardugno Michael H
Executive
GrantCommon Stock$73.1K+43K
+243.42%
59,986
1.07% of shares
low
May 22, 2026Dentzer James E
Director
GrantCommon Stock$24.5K+11K
+292.21%
14,963
0.27% of shares
low
May 22, 2026Pellizzari Christine A
Director
GrantCommon Stock$12.2K+6K
+214.97%
8,142
0.15% of shares
low
Jun 18, 2026Tardugno Michael H
Executive
GrantCommon Stock$8.4K+5K
+36.06%
17,467
0.31% of shares
low
Jun 5, 2026Tardugno Michael H
Executive
GrantCommon Stock$8.4K+4K
+46.74%
12,838
0.23% of shares
low
May 22, 2026Tardugno Michael H
Executive
GrantCommon Stock$7.7K+3K
+66.17%
8,749
0.16% of shares
low
Jan 2, 2026Faller Douglas Vincent
Executive
GrantStock Option (Right to Buy)—+13K
12,667
0.23% of shares
low
Jan 2, 2026Eylward Susan
Executive
GrantStock Option (Right to Buy)—+8K
8,251
0.15% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Armistice Capital, LLCPassive13G—349,917—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
IMNNCommon StockEquity15117N701BBG000BJJGT8